Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium

被引:18
|
作者
Bramlage, C. P. [1 ]
Kaps, C. [2 ]
Ungethuem, U. [3 ]
Bramlage, P. [4 ]
Koziolek, M. [1 ]
Wessels, J. [1 ]
Krenn, V. [5 ]
Pruss, A. [6 ]
Mueller, G. A. [1 ]
Strutz, F. [1 ]
Burmester, G-R. [2 ]
Haeupl, T. [2 ]
机构
[1] Univ Gottingen, Dept Med Nephrol & Rheumatol, D-37075 Gottingen, Germany
[2] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany
[3] Charite Univ Med Berlin, Lab Funct Genome Res, Berlin, Germany
[4] Med Fac Carl Gustav Carus, Inst Clin Pharmacol, Dresden, Germany
[5] Inst Pathol, Trier, Germany
[6] Charite Univ Med Berlin, Inst Transfus Med, Berlin, Germany
关键词
D O I
10.1080/03009740802120010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Growth differentiation factor-5 (GDF-5), a member of the transforming growth factor (TGF)-beta family, is involved in joint development during embryogenesis and has the potential to regenerate cartilage in adult animals. As progression of chronic joint diseases is influenced by cytokines of the synovial tissue, we examined the expression and effects of GDF-5 in this tissue. Methods: Microarray experiments were investigated for differential expression of GDF-5 in synovial tissues, synovial fibroblasts, and peripheral blood cells. GDF-5 expression was validated by semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR), immunohistochemistry, double immunofluorescence, and in situ hybridization in synovial tissue of normal donors (ND) and patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Effects of inflammation and therapy were investigated in RA and OA fibroblasts after stimulation with interleukin (IL)-1 beta, tumour necrosis factor (TNF)-alpha, methotrexate (MTX), and prednisolone. The influence of GDF-5 on macophages was studied by chemotaxis assay. Results: Microarray analysis and immunostaining revealed expression predominantly in synovial fibroblasts. Compared to patients without immunomodulating drugs, expression of GDF-5 was decreased significantly in patients receiving glucocorticoids and/or disease-modifying antirheumatic drugs (DMARDs) (p=0.007), but did not differ between the total group of ND, OA, and RA. Stimulation with prednisolone and TNF alpha reduced GDF-5 expression in OA and RA fibroblasts, whereas MTX and IL-1 beta revealed minor or no relevant change. GDF-5 also reduced cell migration of macrophages (p<0.001). Conclusion: GDF-5 is expressed in synovial fibroblasts and may counteract macrophage infiltration. Its modulation by inflammation and therapy suggests that glucocorticoids play a conflicting role by suppressing not only inflammation but also putative mechanisms of repair.
引用
收藏
页码:401 / 409
页数:9
相关论文
共 50 条
  • [31] Deficient expression of interleukin-10 receptor a chain in rheumatoid arthritis synovium:: limitation of animal models of inflammation
    Neidhart, M
    Jüngel, A
    Ospelt, C
    Michel, BA
    Gay, RE
    Gay, S
    ARTHRITIS AND RHEUMATISM, 2005, 52 (10): : 3315 - 3318
  • [32] Effects of infliximab therapy on biological markers of synovium activity and cartilage breakdown in patients with rheumatoid arthritis
    Marotte, H.
    Gineyts, E.
    Miossec, P.
    Delmas, P. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (07) : 1197 - 1200
  • [33] Expression and function of Gdf-5 during digit skeletogenesis in the embryonic chick leg bud
    Merino, R
    Macias, D
    Gañan, Y
    Economides, AN
    Wang, X
    Wu, Q
    Stahl, N
    Sampath, KT
    Varona, P
    Hurle, JM
    DEVELOPMENTAL BIOLOGY, 1999, 206 (01) : 33 - 45
  • [34] Tissue factor expression in rheumatoid synovium: a potential role in pannus invasion of rheumatoid arthritis
    Chen, Lujun
    Lu, Yahua
    Chu, Yang
    Xie, Jun
    Ding, Wen'ge
    Wang, Fengming
    ACTA HISTOCHEMICA, 2013, 115 (07) : 692 - 697
  • [35] Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis
    Badot, Valerie
    Galant, Christine
    Toukap, Adrien Nzeusseu
    Theate, Ivan
    Maudoux, Anne-Lise
    Van den Eynde, Benoit J.
    Durez, Patrick
    Houssiau, Frederic A.
    Lauwerys, Bernard R.
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (02)
  • [36] Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis
    Valérie Badot
    Christine Galant
    Adrien Nzeusseu Toukap
    Ivan Theate
    Anne-Lise Maudoux
    Benoît J Van den Eynde
    Patrick Durez
    Frédéric A Houssiau
    Bernard R Lauwerys
    Arthritis Research & Therapy, 11
  • [37] Decreased CD20 expression in rheumatoid arthritis synovium following 8 weeks of rituximab therapy
    Walsh, C. A. E.
    Fearon, U.
    FitzGerald, O.
    Veale, D. J.
    Bresnihan, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 656 - 658
  • [38] Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium
    Westman, M
    Korotkova, M
    af Klint, E
    Stark, A
    Audoly, LP
    Klareskog, L
    Ulfgren, AK
    Jakobsson, P
    ARTHRITIS AND RHEUMATISM, 2004, 50 (06): : 1774 - 1780
  • [39] HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients
    Martinez-Ramos, Sara
    Rafael-Vidal, Carlos
    Malvar-Fernandez, Beatriz
    Rodriguez-Trillo, Angela
    Veale, Douglas
    Fearon, Ursula
    Conde, Carmen
    Conde-Aranda, J.
    Radstake, Timothy R. D. J.
    Pego-Reigosa, Jose Maria
    Reedquist, Kris A.
    Garcia, Samuel
    RHEUMATOLOGY, 2023, 62 (07) : 2621 - 2630
  • [40] Expression of cyclooxygenase-1 and-2 in rheumatoid arthritis synovium
    Lee, YH
    Choi, SJ
    Kim, A
    Kim, CH
    Ji, JD
    Song, GG
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2000, 15 (01) : 88 - 92